CG Oncology, Inc. Common stock (CGON) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 9 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for CGON is $79.00, representing a +17.4% upside from the current price of $67.28. Price targets range from a low of $70.00 to a high of $93.00.
